行情

LMNX

LMNX

路明克斯
NASDAQ

实时行情|Nasdaq Last Sale

23.27
-0.48
-2.02%
盘后: 23.27 0 0.00% 16:12 02/21 EST
开盘
23.75
昨收
23.75
最高
23.75
最低
23.27
成交量
24.34万
成交额
--
52周最高
26.82
52周最低
17.35
市值
10.48亿
市盈率(TTM)
-77.5150
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测LMNX价格均价为24.00,最高价位32.00,最低价为18.00。

EPS

LMNX 新闻

更多
  • Luminex Corporation Declares First Quarter Cash Dividend
  • PR Newswire · 5天前
  • Edited Transcript of LMNX earnings conference call or presentation 10-Feb-20 10:00pm GMT
  • Thomson Reuters StreetEvents · 6天前
  • Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020
  • PR Newswire · 02/13 20:10
  • Luminex (LMNX) Earnings and Revenues Beat Estimates in Q4
  • Zacks · 02/11 14:58

所属板块

先进医疗设备和技术
-0.41%
医疗设备和用品
-0.65%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

LMNX 简况

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
展开

微牛提供Luminex Corporation(NASDAQ-LMNX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的LMNX股票新闻,以帮助您做出投资决策。